Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Novel 12-membered non-antibiotic macrolides, EM900 series with anti-inflammatory and/or immunomodulatory activity; synthesis, structure-activity relationships and in vivo study.

× No keyword cloud information.

7 in total

1. Erythromycin acts through the ghrelin receptor to attenuate inflammatory responses in chondrocytes and maintain joint integrity.

Authors: Tomoya Uchimura; Daisy S Nakamura; Eric M Link; Yoshihiko Noguchi; Satoshi Ōmura; Toshiaki Sunazuka; David J Greenblatt; Li Zeng
Journal: Biochem Pharmacol Date: 2019-03-09 Impact factor: 5.858

2. Non-antibiotic 12-membered macrolides: design, synthesis and biological evaluation in a cigarette-smoking model.

Authors: Akihiro Sugawara; Hideaki Shima; Akito Sueki; Tomoyasu Hirose; Hidehito Matsui; Hayato Nakano; Hideaki Hanaki; Kiyoko S Akagawa; Satoshi Ōmura; Toshiaki Sunazuka
Journal: J Antibiot (Tokyo) Date: 2015-09-30 Impact factor: 2.649

3. The non-antibiotic macrolide EM900 inhibits rhinovirus infection and cytokine production in human airway epithelial cells.

Authors: Nadine Lusamba Kalonji; Kazuhiro Nomura; Tetsuaki Kawase; Chiharu Ota; Hiroshi Kubo; Takeya Sato; Teruyuki Yanagisawa; Toshiaki Sunazuka; Satoshi Ōmura; Mutsuo Yamaya
Journal: Physiol Rep Date: 2015-10

Novel 12-membered non-antibiotic macrolides, EM900 series with anti-inflammatory and/or immunomodulatory activity; synthesis, structure-activity relationships and in vivo study.

1. Erythromycin acts through the ghrelin receptor to attenuate inflammatory responses in chondrocytes and maintain joint integrity.

2. Non-antibiotic 12-membered macrolides: design, synthesis and biological evaluation in a cigarette-smoking model.

3. The non-antibiotic macrolide EM900 inhibits rhinovirus infection and cytokine production in human airway epithelial cells.

4. Macrolide derivatives reduce proinflammatory macrophage activation and macrophage-mediated neurotoxicity.

5. Azithromycin Affords Neuroprotection in Rat Undergone Transient Focal Cerebral Ischemia.

6. Penicillin in oral aphthosis, new insight for an old drug: A randomized, double-blind, controlled clinical trial.

7. Development of Novel Erythromycin Derivatives with Inhibitory Activity against Proliferation of Tumor Cells.